Sign in
4

Changes in Ownership

Cadrenal Therapeutics, Inc. Filed Acc 0001213900-23-004882

Director acquired 514,792 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

MURPHY JOHN RAYMOND · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-24 Conversion : show line 1 in the form +514,792 554,792 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-24 Conversion : show line 2 in the form Convertible Promissory Note −514,792 0 D
Loading xslF345X03/ownership.xml…